Publication: Different polarization and functionality of CD4+ T helper subsets in people with post-COVID condition
| dc.contributor.author | Sánchez-Menéndez, Clara | |
| dc.contributor.author | de la Calle-Jiménez, Olivia | |
| dc.contributor.author | Mateos, Elena | |
| dc.contributor.author | Vigon-Hernandez, Lorena | |
| dc.contributor.author | Fuertes, Daniel | |
| dc.contributor.author | Murciano-Antón, María Aranzazu | |
| dc.contributor.author | San José, Esther | |
| dc.contributor.author | García-Gutiérrez, Valentín | |
| dc.contributor.author | Cervero, Miguel | |
| dc.contributor.author | Torres, Montserrat | |
| dc.contributor.author | Coiras, Mayte | |
| dc.contributor.funder | Ministerio de Ciencia e Innovación (España) | |
| dc.contributor.funder | Instituto de Salud Carlos III | |
| dc.contributor.funder | Unión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF) | |
| dc.contributor.funder | Centro de Investigación Biomédica en Red - CIBERINFEC (Enfermedades Infecciosas) | |
| dc.contributor.funder | Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal | |
| dc.date.accessioned | 2024-10-29T14:21:57Z | |
| dc.date.available | 2024-10-29T14:21:57Z | |
| dc.date.issued | 2024 | |
| dc.description.abstract | Introduction: After mild COVID-19 that does not require hospitalization, some individuals develop persistent symptoms that may worsen over time, producing a multisystemic condition termed Post-COVID condition (PCC). Among other disorders, PCC is characterized by persistent changes in the immune system that may not be solved several months after COVID-19 diagnosis. Methods: People with PCC were recruited to determine the distribution and functionality of CD4+ T helper (Th) subsets in comparison with individuals with mild, severe, and critical presentations of acute COVID-19 to evaluate their contribution as risk or protective factors for PCC. Results: People with PCC showed low levels of Th1 cells, similar to individuals with severe and critical COVID-19, although these cells presented a higher capacity to express IFNγ in response to stimulation. Th2/Th1 correlation was negative in individuals with acute forms of COVID-19, but there was no significant Th2/Th1 correlation in people with PCC. Th2 cells from people with PCC presented high capacity to express IL-4 and IL-13, which are related to low ventilation and death associated with COVID-19. Levels of proinflammatory Th9 and Th17 subsets were significantly higher in people with PCC in comparison with acute COVID-19, being Th1/Th9 correlation negative in these individuals, which probably contributed to a more pro-inflammatory than antiviral scenario. Th17 cells from approximately 50% of individuals with PCC had no capacity to express IL-17A and IL-22, similar to individuals with critical COVID-19, which would prevent clearing extracellular pathogens. Th2/Th17 correlation was positive in people with PCC, which in the absence of negative Th1/Th2 correlation could also contribute to the proinflammatory state. Finally, Th22 cells from most individuals with PCC had no capacity to express IL-13 or IL-22, which could increase tendency to reinfections due to impaired epithelial regeneration. Discussion: People with PCC showed skewed polarization of CD4+ Th subsets with altered functionality that was more similar to individuals with severe and critical presentations of acute COVID-19 than to people who fully recovered from mild disease. New strategies aimed at reprogramming the immune response and redirecting CD4+ Th cell polarization may be necessary to reduce the proinflammatory environment characteristic of PCC. | |
| dc.description.peerreviewed | Sí | |
| dc.description.sponsorship | The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was funded by Strategic Action in Health of the Instituto de Salud Carlos III (ISCIII) (grant PI22CIII/00059); the Spanish Ministry of Science and Innovation (grant PID2022-141317OB-I00), funded by MICIU/AEI/10.13039/501100011033 and the European Regional Development Fund (ERDF), EU; and CIBERINFEC (Centro de Investigación Biomédica en Red Enfermedades Infecciosas), co-financed by ERDF “A way to make Europe”. The work of CS-M is financed by Programa Investigo, FIBio HRC IRYCIS, co-financed by ERDF. The work of OC-J is supported by CIBERINFEC (CB21/13/00126). The work of MT is financed by CIBERINFEC (CB21/13/00015). | |
| dc.format.page | 1431411 | |
| dc.format.volume | 15 | |
| dc.identifier.citation | Front Immunol. 2024 Aug 27:15:1431411. | |
| dc.identifier.doi | 10.3389/fimmu.2024.1431411 | |
| dc.identifier.e-issn | 1664-3224 | |
| dc.identifier.journal | Frontiers in immunology | |
| dc.identifier.pubmedID | 39257580 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12105/25373 | |
| dc.language.iso | eng | |
| dc.publisher | Frontiers Media | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/PI22CIII/00059 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/PID2022-141317OB-I00 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/CB21/13/00126 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ES/CB21/13/00015 | |
| dc.relation.publisherversion | https://doi.org/10.3389/fimmu.2024.1431411 | |
| dc.repisalud.centro | ISCIII::Centro Nacional de Microbiología (CNM) | |
| dc.repisalud.institucion | ISCIII | |
| dc.repisalud.institute | IIS::IRYCIS - Instituto Ramón y Cajal de Investigación Sanitaria (Madrid) | |
| dc.rights.accessRights | open access | |
| dc.rights.license | Attribution 4.0 International | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.subject | CD4+ T cells | |
| dc.subject | T helper polarization | |
| dc.subject | Th1 | |
| dc.subject | Th17 | |
| dc.subject | Th2 | |
| dc.subject | Cytokines | |
| dc.subject | Post-covid condition | |
| dc.subject.mesh | Adult | |
| dc.subject.mesh | Aged | |
| dc.subject.mesh | Male | |
| dc.subject.mesh | Female | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Middle Aged | |
| dc.subject.mesh | CD4-Positive T-Lymphocytes | |
| dc.subject.mesh | COVID-19 | |
| dc.subject.mesh | Cytokines | |
| dc.subject.mesh | Post-Acute COVID-19 Syndrome | |
| dc.subject.mesh | SARS-CoV-2 | |
| dc.subject.mesh | T-Lymphocytes, Helper-Inducer | |
| dc.subject.mesh | Th1 Cells | |
| dc.subject.mesh | Th17 Cells | |
| dc.subject.mesh | Th2 Cells | |
| dc.title | Different polarization and functionality of CD4+ T helper subsets in people with post-COVID condition | |
| dc.type | research article | |
| dc.type.hasVersion | VoR | |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | 7d3813df-5a95-4ec9-9511-fec2c9e10e8b | |
| relation.isAuthorOfPublication | 70d4b634-f13f-4b35-a47e-5a337f5acbfc | |
| relation.isAuthorOfPublication | a78af867-a6b0-4c76-a129-d8cfa3e8c85e | |
| relation.isAuthorOfPublication | f044fea9-eb43-475b-8602-1339d49f31f4 | |
| relation.isAuthorOfPublication | f729e106-ee5d-450a-b046-63b14e24c1a3 | |
| relation.isAuthorOfPublication.latestForDiscovery | 7d3813df-5a95-4ec9-9511-fec2c9e10e8b | |
| relation.isFunderOfPublication | 289dce42-6a28-4892-b0a8-c70c46cbb185 | |
| relation.isFunderOfPublication | 7d739953-4b68-4675-b5bb-387a9ab74b66 | |
| relation.isFunderOfPublication | efa64f05-b985-4984-8f1e-5fc4ef21f502 | |
| relation.isFunderOfPublication | 0b5a6d3a-4d4d-4346-9bcc-9359bbe13e72 | |
| relation.isFunderOfPublication | 5f48b5da-242b-496b-940d-aa9884414972 | |
| relation.isFunderOfPublication.latestForDiscovery | 289dce42-6a28-4892-b0a8-c70c46cbb185 | |
| relation.isPublisherOfPublication | 9f9fa5ea-093b-43d8-bf2c-5bd65d08a802 | |
| relation.isPublisherOfPublication.latestForDiscovery | 9f9fa5ea-093b-43d8-bf2c-5bd65d08a802 |


